NPS MedicineWise partnership to strengthen the role of GPs The collaboration builds on a shared goal of improving quality use of medicines, clinical decision making and general practice education.
Which medicines could be in short supply in 2022? The pandemic has proven time and time again that it is a potent driver of shortages – but the end of COVID-induced medicine supply issues may come sooner than expected.
Taking the burden out of anticholinergic medicines A new program targeting the use of anticholinergic medicines has been launched by NPS MedicineWise.
Five-month booster possible ‘in certain circumstances’: ATAGI No changes have been prompted by the Omicron variant, but the advisory group says a shortened minimum gap can be followed if specific conditions are met.
What medicines are prescribed the most in Australia? While statin medications take the lion’s share, antidepressants are being prescribed more, and antibiotics less.
Final call to ‘give something back to the GP community’ Prospective GP mentors are being urged to apply for the RACGP Mentoring Program, with applications set to close on 30 November.
UK study shows surging efficacy after COVID-19 booster The country’s first real-world study since its booster program began shows it is having a significant impact on protection for over-50s.
National Medicines Policy submission focuses on clinical practice Key recommendations for the policy’s review put forward by the RACGP are aimed at ensuring access, safety and quality.
In Practice: What are the latest college submissions? GPs and GPs in training can also learn more about current rural health topics and apply for educational committees.
In Practice: New MBS items Also gain an insight into financially strengthening general practices, new prostate cancer screening processes and childhood disorders.